scholarly journals Gestation-Specific Thyroxine and Thyroid Stimulating Hormone Levels in the United States and Worldwide

2007 ◽  
Vol 29 (5) ◽  
pp. 553-559 ◽  
Author(s):  
Offie P Soldin ◽  
Danielle Soldin ◽  
Marisol Sastoque
Keyword(s):  
United States ◽  
The United States ◽  
Thyroid Stimulating Hormone ◽  
Hormone Levels ◽  
Stimulating Hormone

Thyroid Carcinoma

2007 ◽  
Vol 5 (6) ◽  
pp. 568 ◽  
Author(s):  
_ _
Keyword(s):  
United States ◽  
Thyroid Carcinoma ◽  
The United States ◽  
Mortality Rates ◽  
Thyroid Stimulating Hormone ◽  
Anaplastic Carcinoma ◽  
Recent Version ◽  
Common Malignancy ◽  
Stimulating Hormone

Although thyroid carcinoma is relatively uncommon, approximately 33,550 new cases will be diagnosed in the United States in 2007. It occurs 2 to 3 times more often in women than in men, and with the incidence increasing by 4% per year, it is currently the eighth most common malignancy diagnosed in women. Although it occurs more often in women, mortality rates are higher for men, probably because they are usually older at the time of diagnosis (65–69 years vs. 50–54 years in women). Interestingly, the incidence of thyroid carcinoma increased almost 240% between 1950 and 2000, but mortality rates decreased more than 44%. Important updates to the 2007 guidelines include revised criteria for categorizing disease, revised recommendation for thyroid-stimulating hormone–stimulated thyroglobulin in some cases, and expanded CT recommendations for anaplastic carcinoma. For the most recent version of the guidelines, please visit NCCN.org

Increase in thyroid stimulating hormone levels in patients with gout treated with inhibitors of xanthine oxidoreductase

2015 ◽  
Vol 35 (11) ◽  
pp. 1857-1861 ◽  
Author(s):  
Fernando Perez-Ruiz ◽  
Sandra Pamela Chinchilla ◽  
Joana Atxotegi ◽  
Irati Urionagüena ◽  
Ana Maria Herrero-Beites ◽  
...  
Keyword(s):  
Thyroid Stimulating Hormone ◽  
Xanthine Oxidoreductase ◽  
Hormone Levels ◽  
Stimulating Hormone

scholarly journals Normalization of thyroid stimulating hormone levels in acromegalic patients after selective adenomectomy.

1984 ◽  
Vol 31 (6) ◽  
pp. 687-695 ◽  
Author(s):  
HIROYASU TSUCHIYA ◽  
TOSHIO ONISHI ◽  
SHINTARO MORI ◽  
SHOUSHI LEE ◽  
HIROSHI KOHNO ◽  
...  
Keyword(s):  
Thyroid Stimulating Hormone ◽  
Hormone Levels ◽  
Stimulating Hormone

Low Thyroid-stimulating Hormone Levels Are Associated With Annoying Tinnitus in Adult Women

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
So Young Kim ◽  
Chanyang Min ◽  
Hyung-Jong Kim ◽  
Hyo Geun Choi
Keyword(s):  
Thyroid Stimulating Hormone ◽  
Adult Women ◽  
Hormone Levels ◽  
Stimulating Hormone

scholarly journals Thyroid-stimulating hormone levels in newborns and early life exposure to endocrine-disrupting chemicals: analysis of three European mother–child cohorts

2017 ◽  
Vol 82 (3) ◽  
pp. 429-437 ◽  
Author(s):  
Marijke de Cock ◽  
Michiel R de Boer ◽  
Eva Govarts ◽  
Nina Iszatt ◽  
Lubica Palkovicova ◽  
...  
Keyword(s):  
Early Life ◽  
Endocrine Disrupting Chemicals ◽  
Thyroid Stimulating Hormone ◽  
Hormone Levels ◽  
Early Life Exposure ◽  
Endocrine Disrupting ◽  
Stimulating Hormone

scholarly journals The association of thyroid stimulating hormone levels with cognitive function and depressed mood: The Rancho Bernardo study

2009 ◽  
Vol 13 (4) ◽  
pp. 317-321 ◽  
Author(s):  
D. Kritz-Silverstein ◽  
S. T. Schultz ◽  
L. A. Palinkas ◽  
D. L. Wingard ◽  
E. Barrett-Connor
Keyword(s):  
Cognitive Function ◽  
Depressed Mood ◽  
Thyroid Stimulating Hormone ◽  
Hormone Levels ◽  
Stimulating Hormone

scholarly journals SAT-447 Thyroid Function, Cardiovascular Disease, and Mortality: A Mediation Analysis

2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
Kosuke Inoue ◽  
Beate Ritz ◽  
Gregory A Brent ◽  
Ramin Ebrahimi ◽  
Connie Rhee ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Mediation Analysis ◽  
Subclinical Hypothyroidism ◽  
The United States ◽  
Thyroid Stimulating Hormone ◽  
Mediation Effect ◽  
Mortality Data ◽  
All Cause Mortality ◽  
The U.S ◽  
Stimulating Hormone

Abstract Background: Subclinical hypothyroidism is a common clinical entity among the United States (U.S) adults and has been associated with increased risk of cardiovascular disease (CVD) and mortality in some studies. However, the mediation effect of CVD from elevated serum thyroid stimulating hormone (TSH) to mortality has not yet been well established or sufficiently quantified. In this study, we aimed to elucidate the extent to which subclinical hypothyroidism or high-normal thyroid stimulating hormone [TSH] concentrations (i.e. upper normative-range TSH concentrations) contribute to mortality through its effect on CVD among U.S. adults. Methods: This study relies on the U.S. representative samples of 9,020 adults enrolled in the National Health and Nutrition Examination Surveys (NHANES) 2001-2002, 2007-2012 and their mortality data through 2015. We employed Cox proportional hazards regression models to investigate associations between the TSH concentration categories (subclinical hypothyroidism or tertiles of serum TSH concentrations within the reference range) and all-cause mortality. Utilizing mediation analysis within the counterfactual framework, we estimated the mediation effect of CVD on the association between TSH and all-cause mortality. Results: The median duration of follow-up for mortality ascertainment was 7.3 (interquartile range, 5.4–8.3) years, during which 435 deaths from all causes were identified. Subjects with TSH in the subclinical hypothyroidism and the high-normal TSH tertile concentrations were associated with increased all-cause mortality (subclinical hypothyroidism: hazard ratio [HR], 1.90; 95% confidence interval [CI], 1.14–3.19; high-normal TSH: HR, 1.36; 95% CI, 1.07–1.73) compared with the middle-normal TSH tertile concentration. CVD mediated 14.3% and 5.9% of the effects of subclinical hypothyroidism and high-normal TSH on all-cause mortality, respectively, with the CVD mediation effect being most pronounced in women and subjects ≥60 years old. No mediation through CVD was found for low-normal TSH levels and all-cause mortality. Conclusion: CVD mediated the effects of subclinical hypothyroid and high-normal TSH concentrations on all-cause mortality in the U.S. general population. These findings may have potential implications for treatment, and early and more aggressive CVD screening for such at risk populations. Further studies are needed to examine the clinical impact of targeted therapy towards mid-normal TSH concentration.

Thyroid stimulating hormone levels and BRAFV600E mutation contribute to pathophysiology of papillary thyroid carcinoma: Relation to outcomes?

2019 ◽  
Vol 26 (2) ◽  
pp. 129-135 ◽  
Author(s):  
Oksana Sulaieva ◽  
Olena Chernenko ◽  
Yelisaveta Chereshneva ◽  
Dibahan Tsomartova ◽  
Oleksandr Larin
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Thyroid Stimulating Hormone ◽  
Papillary Thyroid ◽  
Brafv600e Mutation ◽  
Hormone Levels ◽  
Stimulating Hormone
Sign in / Sign up

Export Citation Format

Share Document